Citation 127182

KO,KM: YICK,PK: POON,MKT: CHE,CT: NG,KH: KONG,YC:. (1995). SCHISANDRA CHINENSIS-DERIVED ANTIOXIDANT ACTIVITIES IN 'SHENG MAI SAN', A COMPOUND FORMULATION, IN VIVO AND IN VITRO.. 9(3)

Citation Details

Title	SCHISANDRA CHINENSIS-DERIVED ANTIOXIDANT ACTIVITIES IN 'SHENG MAI SAN', A COMPOUND FORMULATION, IN VIVO AND IN VITRO.
Authors	KO,KM: YICK,PK: POON,MKT: CHE,CT: NG,KH: KONG,YC:
Year	1995
Volume	9
Issue	3

Summary

Year: 1995

Journal: Unknown

Organisms and Their Experiments (3)

Panax ginseng (ARALIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CARDIOVASCULAR EFFECTS(UNSPECIFIED)	EFFECTS DUE TO A COMBINATION OF DRUGSMEDICINAL FOLKLORE REPORTED FOR	None	None
2	GLUTATHIONE DEPLETION INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
3	GLUTATHIONE DEPLETION INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
4	GLUTATHIONE DEPLETION INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
5	LIPID PEROXIDE FORMATION INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
6	ALT VALUE DECREASED	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
7	LIPID PEROXIDE FORMATION INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
8	ALT VALUE DECREASED	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
9	LIPID PEROXIDE FORMATION INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
10	ALT VALUE DECREASED	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
11	SUPEROXIDE RADICAL SCAVENGING ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
12	SUPEROXIDE RADICAL SCAVENGING ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
13	SUPEROXIDE RADICAL SCAVENGING ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	WEAK ACTIVITY

Ophiopogon japonicus (LILIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CARDIOVASCULAR EFFECTS(UNSPECIFIED)	EFFECTS DUE TO A COMBINATION OF DRUGSMEDICINAL FOLKLORE REPORTED FOR	None	None
2	GLUTATHIONE DEPLETION INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
3	GLUTATHIONE DEPLETION INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
4	GLUTATHIONE DEPLETION INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
5	LIPID PEROXIDE FORMATION INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
6	ALT VALUE DECREASED	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
7	LIPID PEROXIDE FORMATION INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
8	ALT VALUE DECREASED	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
9	LIPID PEROXIDE FORMATION INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
10	ALT VALUE DECREASED	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
11	SUPEROXIDE RADICAL SCAVENGING ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
12	SUPEROXIDE RADICAL SCAVENGING ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	WEAK ACTIVITY
13	SUPEROXIDE RADICAL SCAVENGING ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE

Schisandra chinensis (SCHISANDRACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CARDIOVASCULAR EFFECTS(UNSPECIFIED)	EFFECTS DUE TO A COMBINATION OF DRUGSMEDICINAL FOLKLORE REPORTED FOR	None	None
2	GLUTATHIONE DEPLETION INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
3	GLUTATHIONE DEPLETION INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
4	GLUTATHIONE DEPLETION INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
5	LIPID PEROXIDE FORMATION INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
6	ALT VALUE DECREASED	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
7	LIPID PEROXIDE FORMATION INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
8	ALT VALUE DECREASED	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
9	ALT VALUE DECREASED	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
10	LIPID PEROXIDE FORMATION INHIBITION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
11	SUPEROXIDE RADICAL SCAVENGING ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
12	SUPEROXIDE RADICAL SCAVENGING ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
13	SUPEROXIDE RADICAL SCAVENGING ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
14	SUPEROXIDE RADICAL SCAVENGING ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	STRONG ACTIVITY

Show SPARQL Queries (1)